Suggestions
Maren Winnick
Senior Managing Director, Biopharma Investment Banking at Evercore
Maren Winnick is a Senior Managing Director and partner at Evercore, a global investment banking advisory firm.1 She plays a key role in leading the firm's biotech investment banking business, specializing in strategic advisory services for the biopharmaceutical sector.12
Professional Background
Maren Winnick has an extensive career in finance and biotech:
- Current Role: Senior Managing Director at Evercore, focusing on strategic advisory for the biopharmaceutical sector12
- Previous Positions:
Expertise and Achievements
At Evercore, Maren Winnick has demonstrated significant expertise in various areas:
- Transaction Advisory: She advises clients on strategic and financing transactions, including mergers and acquisitions, complex partnering, and activism and raid defense1
- Capital Raising: Winnick has helped clients raise over $20 billion across more than 75 IPOs, follow-on offerings, convertibles, and private capital raises1
- Notable Transactions: Her recent M&A deals include DTx's $1 billion sale to Novartis, Editas Medicine's cell therapy sale to Shoreline, Carisma Therapeutic's sale and reverse merger with Sesen Bio, and Translate Bio's $3.2 billion sale to Sanofi1
Leadership and Diversity Initiatives
Maren Winnick is actively involved in promoting diversity and inclusion within Evercore:
- Co-head of the Evercore Women's Network1
- Member of the firm's Diversity, Equity and Inclusion (DE&I) Leadership Committee1
Education
Maren Winnick's extensive experience in investment banking, particularly in the biotech and healthcare sectors, combined with her leadership roles and commitment to diversity initiatives, make her a prominent figure in the field of biopharma investment banking.
